Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
All Congress filingsSearch insider filingsEarnings calendarWatchlist
MORE TOOLS
Gold IntelligenceSilver IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeAll Congress filingsSearch insider filings
More research tools
ExploreGold IntelligenceSilver IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…

CongressSearchHomeWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
LOOK INSIDE THE BUSINESS

Company financials.

Explore company-wide revenue, income and balance-sheet facts directly from SEC filings.

View EDSA insider activity ↗

EDSAEdesa Biotech, Inc.

THE LATEST REPORTED YEAR

The company reported a loss.

$7.19M net loss for the year ended September 30, 2025. These are reported results, not a forecast or a stock recommendation.

Revenue$0Year ended September 30, 2021
Profit or loss-$7.19MYear ended September 30, 2025
Cash from the business-$7.32MYear ended September 30, 2025
Total assets$12.72MAs of June 30, 2026
Total liabilities$1.83MAs of September 30, 2024
Cash & equivalents$10.3MAs of June 30, 2026
THE BUSINESS BEHIND THE TICKER

Revenue, over time.

Latest-filed standard financial facts · USD

$545.47K
2013-08
$372.13K
2014-08
$758.69K
2015-09
$1.27M
2016-09
$228.29K
2017-09
$211.85K
2018-09
$328.8K
2020-09
$0
2021-09

Bars show magnitude; labels retain the sign. Each observation covers a reported annual period of 330–400 days; transition years can differ.

From the filing

Reported periods can differ from calendar years. Later filings may restate earlier figures. These are company-wide facts; product and geographic revenue segments are not included.

Reported periodReported valueFiledSource
October 1, 2020 – September 30, 2021$0December 28, 202110-K ↗
October 1, 2019 – September 30, 2020$328,801December 28, 202110-K ↗
October 1, 2017 – September 30, 2018$211,849November 30, 201810-K ↗
October 1, 2016 – September 30, 2017$228,287November 30, 201810-K ↗
October 1, 2015 – September 30, 2016$1,271,689December 1, 201710-K ↗
October 1, 2014 – September 30, 2015$758,689December 1, 201710-K ↗
September 1, 2013 – August 31, 2014$372,132December 14, 201610-K ↗
September 1, 2012 – August 31, 2013$545,469December 14, 201510-K ↗
Source and calculation details

One standard US-GAAP or IFRS concept is selected per metric, using USD only. Annual durations must be 330–400 days. Quarterly durations must be 70–110 days; year-to-date totals are excluded, and fourth quarters are never inferred by subtraction. Cash-flow quarters can therefore be sparse. Conflicting values filed on the same day are excluded. Latest-filed values are used, so these observations must not be treated as facts known in an earlier backtest.

Concept: us-gaap:Revenues · Retrieved October 16, 2026

Response SHA-256: 0f44de1ccf1eff46a1af17dc21d4a3bb38216bbf46e813f5a136d29e08bfd65d

SEC company facts

Company-wide USD figures from SEC filings. Each card keeps its own reporting date; later filings can revise earlier results.